Caris Life Sciences, Inc. (CAI)
NASDAQ: CAI · Real-Time Price · USD
23.76
+0.05 (0.21%)
At close: Nov 18, 2025, 4:00 PM EST
23.69
-0.07 (-0.29%)
After-hours: Nov 18, 2025, 5:11 PM EST

Caris Life Sciences Stock Forecast

Stock Price Forecast

The 6 analysts that cover Caris Life Sciences stock have a consensus rating of "Strong Buy" and an average price target of $35.5, which forecasts a 49.41% increase in the stock price over the next year. The lowest target is $31 and the highest is $42.

Price Target: $35.5 (+49.41%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$31$35.5$36$42
Change+30.47%+49.41%+51.52%+76.77%
* Price targets were last updated on Aug 13, 2025.

Analyst Ratings

The average analyst rating for Caris Life Sciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingJun '25Jul '25Aug '25Sep '25Oct '25Nov '25
Strong Buy033333
Buy033333
Hold300000
Sell000000
Strong Sell000000
Total366666

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Guggenheim
Guggenheim
Strong Buy
Maintains
$32$36
Strong BuyMaintains$32$36+51.52%Aug 13, 2025
Evercore ISI Group
Evercore ISI Group
Buy
Maintains
$33$40
BuyMaintains$33$40+68.35%Aug 13, 2025
Citigroup
Citigroup
Strong Buy
Maintains
$34$42
Strong BuyMaintains$34$42+76.77%Aug 13, 2025
Evercore ISI Group
Evercore ISI Group
Buy
Initiates
$33
BuyInitiates$33+38.89%Jul 15, 2025
TD Cowen
TD Cowen
Strong Buy
Initiates
$32
Strong BuyInitiates$32+34.68%Jul 14, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
678.81M
from 412.26M
Increased by 64.66%
Revenue Next Year
989.77M
from 678.81M
Increased by 45.81%
EPS This Year
-2.55
from -10.66
EPS Next Year
0.28
from -2.55
Fiscal YearFY 2022FY 2023FY 2024FY 2025FY 2026FY 2027FY 2028
Period EndingDec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026Dec 31, 2027Dec 31, 2028
Revenue
258.49M306.13M412.26M678.81M989.77M1.23B1.41B
Revenue Growth
-18.43%34.67%64.66%45.81%24.07%15.15%
EPS
-11.98-13.24-10.66-2.550.281.101.61
EPS Growth
-----291.63%45.65%
Forward PE
----84.3921.5514.80
No. Analysts
---9984
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20252026202720282029
High718.5M1.1B
Avg678.8M989.8M
Low594.7M936.3M

Revenue Growth

Revenue Growth20252026202720282029
High
74.3%
55.7%
Avg
64.7%
45.8%
Low
44.2%
37.9%

EPS Forecast

EPS20252026202720282029
High-0.890.51
Avg-2.550.28
Low-8.68-0.05

EPS Growth

EPS Growth20252026202720282029
High--
Avg--
Low--
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.